rs35520756

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024649.5(BBS1):​c.700G>A​(p.Glu234Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00546 in 1,613,416 control chromosomes in the GnomAD database, including 409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 216 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 193 hom. )

Consequence

BBS1
NM_024649.5 missense

Scores

2
7
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:12

Conservation

PhyloP100: 5.86

Publications

16 publications found
Variant links:
Genes affected
BBS1 (HGNC:966): (Bardet-Biedl syndrome 1) Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008]
BBS1 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Myriad Women’s Health, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036582947).
BP6
Variant 11-66519725-G-A is Benign according to our data. Variant chr11-66519725-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 12148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS1NM_024649.5 linkc.700G>A p.Glu234Lys missense_variant Exon 8 of 17 ENST00000318312.12 NP_078925.3 Q8NFJ9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS1ENST00000318312.12 linkc.700G>A p.Glu234Lys missense_variant Exon 8 of 17 1 NM_024649.5 ENSP00000317469.7 Q8NFJ9-1
ENSG00000256349ENST00000419755.3 linkc.811G>A p.Glu271Lys missense_variant Exon 8 of 17 2 ENSP00000398526.3

Frequencies

GnomAD3 genomes
AF:
0.0294
AC:
4464
AN:
151898
Hom.:
216
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000625
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.0187
GnomAD2 exomes
AF:
0.00768
AC:
1927
AN:
251044
AF XY:
0.00543
show subpopulations
Gnomad AFR exome
AF:
0.105
Gnomad AMR exome
AF:
0.00474
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00297
AC:
4343
AN:
1461400
Hom.:
193
Cov.:
31
AF XY:
0.00248
AC XY:
1800
AN XY:
727026
show subpopulations
African (AFR)
AF:
0.104
AC:
3483
AN:
33474
American (AMR)
AF:
0.00537
AC:
240
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26134
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53036
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
0.000185
AC:
206
AN:
1111928
Other (OTH)
AF:
0.00606
AC:
366
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
252
503
755
1006
1258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0294
AC:
4474
AN:
152016
Hom.:
216
Cov.:
32
AF XY:
0.0283
AC XY:
2100
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.102
AC:
4223
AN:
41446
American (AMR)
AF:
0.0115
AC:
175
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.000626
AC:
3
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
67988
Other (OTH)
AF:
0.0185
AC:
39
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
196
391
587
782
978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0116
Hom.:
201
Bravo
AF:
0.0339
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0995
AC:
438
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.00928
AC:
1127
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000533

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bardet-Biedl syndrome 1 Benign:4
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 08, 2021
Ocular Genomics Institute, Massachusetts Eye and Ear
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

The BBS1 c.700G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: BS1, BS2. Based on this evidence we have classified this variant as Benign. -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 11, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12567324, 20498079, 27894351, 29191167, 20981092, 27884173) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 1/7, digenic Pathogenic:1
Mar 01, 2003
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

BBS1-related ciliopathy Benign:1
Apr 24, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.68
.;D;.;.
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
D;D;D;D
MetaRNN
Benign
0.0037
T;T;T;T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
1.8
.;L;.;L
PhyloP100
5.9
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-2.3
N;N;D;N
REVEL
Uncertain
0.55
Sift
Benign
0.089
T;T;T;T
Sift4G
Uncertain
0.034
D;D;D;T
Polyphen
0.99
.;D;.;.
Vest4
0.34
MVP
0.95
MPC
0.29
ClinPred
0.056
T
GERP RS
5.6
Varity_R
0.16
gMVP
0.58
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35520756; hg19: chr11-66287196; COSMIC: COSV59150566; COSMIC: COSV59150566; API